ASXL1 and acute myeloid leukemia: The majority of pathogenic variants in this study disrupt the latter half of the protein-coding region encoded by the last two exons of ASXL1. Figure 1B illustrates the germline BOS variants and somatic AML-ASXL1 variants across the ASXL1 gene in this study.